Back to results
US 5,852,044 AGranted
Use of NK.sub.1 receptor antagonists for preparing cardio-regulatory drugs
AssigneeSanofi
InventorsChristiane Gueudet, Vincent Santucci, Philippe Soubrie
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of NK.sub.1 receptor antagonists for the preparation of drugs with a cardioregulatory action, intended in particular for controlling heart rate disorders and cardiac dysrhythtmia.
Claims5
A method for controlling heart rate disorders in a patient in need thereof which comprises administering to the patient an effective amount for controlling heart rate disorders of NK.sub.1 receptor antagonist having a formula ##STR115## in which;
- A is a pharmaceutically acceptable anion.
Dependencies are inferred from the claim text.